A systematic methodology, able to assess risk and predict clinical safety and efficacy of Substances of Human Origin’ (SoHO) has been developed. The model consists of a risk based approach taking into account factors such as novelty of the product, preparation process, clinical indication, and its technical complexity.
EuroGTPII: a tool to assess risk, safety and efficacy of substances of human origin
ELISABETTA MARTON
2019
Abstract
A systematic methodology, able to assess risk and predict clinical safety and efficacy of Substances of Human Origin’ (SoHO) has been developed. The model consists of a risk based approach taking into account factors such as novelty of the product, preparation process, clinical indication, and its technical complexity.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
EuroGTP II a tool to assess risk_supplement.pdf
Accesso riservato
Descrizione: Supplemento lista autori
Tipologia:
Published (Publisher's Version of Record)
Licenza:
Accesso privato - non pubblico
Dimensione
23.94 kB
Formato
Adobe PDF
|
23.94 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.




